Brief: Scope Fluidics' Bacteromic Signs Agreement With Comac Medical For Clinical Trials Of Bacteromic PBC Panel
01/07/2026 07:10
BRIEF-Scope Fluidics' Bacteromic Signs Agreement With Comac Medical For Clinical Trials Of Bacteromic PBC Panel July 1 (Reuters) - Scope Fluidics SA SCPP.WA:
BACTEROMIC SIGNS AGREEMENT WITH COMAC MEDICAL FOR CLINICAL TRIALS OF BACTEROMIC PBC PANEL
ESTIMATED COST OF CLINICAL TRIALS NOT TO EXCEED EUR 1 MILLION
IVDR CERTIFICATION FOR BACTEROMIC PBC PANEL EXPECTED IN 2027
Source text: ID:nEM54QcMma
Further company coverage: SCPP.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Scope Fluidics SA
See all newsBrief: Scope Fluidics' EDOCERA Project Meets Second Goal Of Developing Prototype Of Device For Detecting Stroke Symptoms
Brief: Scope Fluidics Q2 Net Loss At 10.1 Million Zlotys
Brief: Scope Fluidics Unit Signs Deal With Poland's PARP For Up To 14.4 Mln Zlotys In Funding For HYBOLIC Project
Brief: Scope Fluidics Says FDA Certification For UNI FAST Panel Planned For Second Half Of 2027
Brief: Scope Fluidics Extends Deadline For First Goal In Hybolic Project